2BB score and signals
Zevra Therapeutics, Inc.’s current 2BB score is 56 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 53 | Moderate |
| Momentum | 46 | Stable |
| Financial strength | 75 | Strong |
| Quality | 80 | Very Strong |
| Risk | 40 | Low |
Company facts
| Founded | 2006 |
| Employees | 61 |
| P/E ratio | 11.95 |
| 52-week range | $7.16 – $15.04 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-03 | — | 0.1598 | — | $37.82M |
| 2026-08-05 | — | 0.1095 | — | $34.56M |
| 2026-05-06 | 0.18 | 0.0824 | $36.22M | $32.60M |
| 2026-03-09 | 0.21 | 0.051 | $34.12M | $28.61M |
Related companies
